Theres no outrunning the GLP-1 wave Given the ongoing wave of media coverage, a class of drugs known as GLP-1 agonists is becoming increasingly well-known
Upward trends in overweight and obesity in adults with T1D seen in other countries, including Finland, Sweden, Italy, and Germany/Austria, mirror those of the United States
Can poor blood flow slow connective tissue healing
Understanding the appropriate steps when doses are delayed helps ensure safe, effective treatment whilst minimising potential side effects
Maintaining treatment with semaglutide compared with placebo resulted in continued weight loss over the following 48 week as in STEP 4 Rubino D et al
You can begin your path to better health without hours-long wait times at an office